Skip to main content

Potent anticancer activity of (Z)‑3‑hexenyl‑β‑D‑glucopyranoside in pancreatic cancer cells

Research Abstract

This current study reports, for the first time, on the potent cytotoxicity of (Z)-3-hexenyl-β-D-glucopyranoside, as well as
its cellular and molecular apoptotic mechanisms against Panc1 cancer cells. The cytotoxicity of three compounds, namely
(Z)-3-hexenyl-β-D-glucopyranoside (1), gallic acid (2), and pyrogallol (3), which were isolated from C. rotang leaf, was
investigated against certain cancer and normal cells using the MTT assay. The cellular apoptotic activity and Panc1 cell cycle
impact of compound (1) were examined through flow cytometry analysis and Annexin V-FITC cellular apoptotic assays.
Additionally, RT-PCR was employed to evaluate the effect of compound (1) on the Panc1 apoptotic genes Casp3 and Bax,
as well as the antiapoptotic gene Bcl-2. (Z)-3-hexenyl-β-D-glucopyranoside demonstrated the highest cytotoxic activity
against Panc1 cancer cells, with an IC50
value of 7.6 μM. In comparison, gallic acid exhibited an IC50
value of 21.8 μM, and
pyrogallol showed an IC50
value of 198.2 μM. However, (Z)-3-hexenyl-β-D-glucopyranoside displayed minimal or no significant
cytotoxic activity against HepG2 and MCF7 cancer cells as well as WI-38 normal cells, with IC50
values of 45.8 μM,
108.7 μM, and 194. μM, respectively. (Z)-3-hexenyl-β-D-glucopyranoside (10 μM) was demonstrated to induce cellular
apoptosis and cell growth arrest at the S phase of the cell cycle in Panc1 cells. These findings were supported by RT-PCR
analysis, which revealed the upregulation of apoptotic genes (Casp3 and Bax) and the downregulation of the antiapoptotic
gene Bcl-2. This study emphasizes the significant cellular potency of (Z)-3-hexenyl-β-D-glucopyranoside in specifically
inducing cytotoxicity in Panc1 cells.

Research Authors
Ahmed M. Zaher, Walaa S. Anwar, Makboul A. Makboul, Iman A. M. Abdel‑Rahman
Research Date
Research Department
Research File
Research Journal
Naunyn-Schmiedeberg's Archives of Pharmacology
Research Website
https://doi.org/10.1007/s00210-023-02755-4
Research Year
2023

Potent hepatoprotective activity of common rattan (Calamus rotang L.) leaf extract and its molecular mechanism

Research Abstract

Abstract
Background Calamus rotang L. (CR) is an Indian shrub. The leaves and other organs of the plant are traditionally used
in India for treatment of various diseases. The in vitro antioxidant property of the leaves extract was previously established.
Thus, the current study aimed to evaluate the antioxidant and hepatoprotective effects of CR ethyl acetate
extract at a dose of 350 mg/kg on CCl4
induced hepatotoxic rats through different mechanisms.
Methods Histopathological examination of the treated rats’ group in comparison with positive and negative controls
were performed. Quantitative measuring of the proinflammatory cytokines (TNF α), inflammatory regulators
(Arginase, PPAR α) and the antiapoptotic protein Bcl-2 in comparison with positive and negative control groups was
achieved using immunohistochemical examination. HPLC profiling of the polyphenol contents and molecular docking
of the identified compounds against BH3 proapoptotic protein were correspondingly studied to evaluate the
potential antiapoptotic property.
Results The CR extract greatly protects the liver tissue through the suppression of TNF α, arginase and PPAR α
induced by CCl4
as well as its enhancement of the antiapoptotic Bcl-2 protein. Fourteen polyphenols of different
classes were identified in CR extract and tested via molecular docking for their potential antiapoptotic activities
against BH3 protein. Naringin, rutin, 7-hydroxy flavone, and ellagic acid compounds exhibit the highest affinity and
potential inhibition of pro-apoptotic protein BH3 via molecular docking study.
Conclusions The ethyl acetate fraction of the leaves of C. rotang is rich in polyphenols that exhibited potent hepatoprotective
effect on CCl4
induced hepatotoxic rats through its antioxidant, anti-inflammatory, anti-steatosis and
antiapoptotic properties

Research Authors
Walaa S. Anwar, Fatma M. Abdel‑maksoud, Ahmed M. Sayed, Iman A. M. Abdel‑Rahman, Makboul A. Makboul and Ahmed M. Zaher
Research Date
Research Department
Research Journal
BMC Complementary Medicine and Therapies
Research Website
https://doi.org/10.1186/s12906-023-03853-9
Research Year
2023

Meeting of the Council of the Clinical Pharmacy Department, Faculty of Pharmacy will be held on Thursday, May 9, 2024

God willing, the Clinical Pharmacy Department Council will hold its regular monthly meeting number (101) on Thursday, May 9, 2024 at at 12 :00 AM.

in the meetings Hall of the Department - 5th floor (Building A)

In the department council meeting room

news category
خبر عام

Meeting of the Council of the Pharmaceutics Department, Faculty of Pharmacy on Wednesday, May 8, 2024

God willing, the meeting of the Pharmaceutics Department Board of the Faculty of Pharmacy No. (526) this will be on Wednesday, May 8, 2024, at 10:00 A.M

in the department board on the third floor under the chairmanship of the Faculty to discuss the topics that we will inform you later.

news category
خبر عام

Evaluating anthelmintic, anti‑platelet, and anti‑coagulant activities, and identifying the bioactive phytochemicals of Amaranthus blitum L.

Research Abstract

Background Highlighting afordable alternative crops that are rich in bioactive phytoconstituents is essential 
for advancing nutrition and ensuring food security. Amaranthus blitum L. (AB) stands out as one such crop with a traditional history of being used to treat intestinal disorders, roundworm infections, and hemorrhage. This study aimed to evaluate the anthelmintic and hematologic activities across various extracts of AB and investigate the phytoconstituents responsible for these activities.
Methods In vitro anthelmintic activity against Trichinella spiralis was evaluated in terms of larval viability reduction. The anti-platelet activities were assessed based on the inhibitory efect against induced platelet aggregation. Further, efects on the extrinsic pathway, the intrinsic pathway, and the ultimate common stage of blood coagulation, were monitored through measuring blood coagulation parameters: prothrombin time (PT), activated partial thromboplastin time (aPTT), and thrombin time (TT), respectively. The structures of isolated compounds were elucidated by spectroscopic analysis.
Results Interestingly, a previously undescribed compound (19), N-(cis-p-coumaroyl)-ʟ-tryptophan, was iso‑
lated and identifed along with 21 known compounds. Signifcant in vitro larvicidal activities were demonstrated 
by the investigated AB extracts at 1mg/mL. Among tested compounds, compound 18 (rutin) displayed the high‑
est larvicidal activity. Moreover, compounds 19 and 20 (N-(trans-p-coumaroyl)-ʟ-tryptophan) induced complete 
larval death within 48h. The crude extract exhibited the minimal platelet aggregation of 43.42±11.69%, compared 
with 76.22±14.34% in the control plasma. Additionally, the crude extract and two compounds 19 and 20 signifcantly inhibited the extrinsic coagulation pathway.
Conclusions These fndings extend awareness about the nutritional value of AB as a food, with thrombosis-preventing capabilities and introducing a promising source for new anthelmintic and anticoagulant agents

Research Authors
Ghada Abdel‑Moez, Hanaa Sayed, Azza Khalifa, Salwa Abd‑Elrahman, Mohammed Osman and Shaymaa Mohamed
Research Date
Research Department
Research Journal
BMC Complementary Medicine and Therapies
Research Publisher
Springer Nature
Research Rank
Q2
Research Vol
24
Research Website
https://link.springer.com/content/pdf/10.1186/s12906-024-04478-2.pdf
Research Year
2024
Subscribe to